Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Cynvenio Biosystems have signed a distribution agreement for Cynvenio's LiquidBiopsy platform, the companies said today.

Cynvenio's LiquidBiopsy platform is designed to extract and isolate circulating tumor cells from a blood draw and prepare them for imaging and genomic analysis. According to Cynvenio's website, the platform uses a patented microfluidic chip to recover tumor cells from whole blood and can process up to four samples in under three hours.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.